Neurol. praxi. 2024;25(1):71-73 | DOI: 10.36290/neu.2023.080

Patient with myopathy… or not?

MUDr. Jana Junkerová, MUDr. Eva Kovalová, MUDr. Martin Sabela
Neurologická klinika Fakultní nemocnice Ostrava
Lékařská fakulta Ostravské univerzity

The clinical picture of the disease is a essential factor for determining the correct diagnosis and thus the treatment procedure. It is not uncommon that etiopathogenetically different processes can lead to outwardly visible symptoms. The similarity of the phenotype of hereditary myopathies and adult forms of spinal muscular atrophy (SMA) is known - mainly SMA III. type, Kugelberg-Welander, sometimes directly referred to as pseudomyopathic. In the light of the new possibilities of therapeutically influencing the SMA gene mutation, we remind you of the urgency of revising the diagnoses of adult patients who give the impression of myopaths. Diametrically different are not only the genes affected by the mutation and the level of the motor pathway lesion, but above all the current treatment options.

Keywords: spinal muscular atrophy, myopathy, loss of muscle mass, neurogenic, myogenic.

Received: December 9, 2023; Revised: December 9, 2023; Accepted: December 18, 2023; Prepublished online: December 18, 2023; Published: March 6, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Junkerová J, Kovalová E, Sabela M. Patient with myopathy… or not? Neurol. praxi. 2024;25(1):71-73. doi: 10.36290/neu.2023.080.
Download citation

References

  1. Ambler Z. Klinická neurologie - část speciální II. Praha: Triton. 2010;786-7 s. ISBN 978-80-7387-389-9.
  2. Ambler Z. Poruchy periferních nervů. Praha: Triton. 2013; 93-104 s. ISBN 978-80-7387-705-7.
  3. Bednařík J. a kol. Nemoci kosterního svalstva. Praha: Triton. 2001; 76 s, 84 s, 93 s, 133-4 s. ISBN 80-7254-187-0.
  4. Butchbach M. Genomic Variability in the Survival Motor Neuron Genes (SMN1 and SMN2): Implications for Spinal Muscular Atrophy Phenotype and Therapeutics Development. Int J Mol Sci. 2021:22(15):7896. Go to original source... Go to PubMed...
  5. Haberlová J, Slabá A, Hedvičáková et al. Spinální svalové atrofie - diagnostika, léčba, výzkum. Neurol. praxi. 2016;17(6):349-353. Go to original source...
  6. Kimura J. Electrodiagnosis in Diseases of Nerve and Muscle: Principles and Practice, edition 3. Oxford University Press. 2001; 608 p. ISBN 13987-0-19-512977-9.
  7. Preston DC, Shapiro BE. Electromyography and Neuromuscular Disorders, clinical - electrophysiologic­‑ultrasound correlations. Philadelphia: Elsevier. 2021; 677 p. ISBN 978-0-323-66180-5.
  8. Tai­‑Heng Chen. New and Developing Therapies in Spinal Muscular Atrophy: From Genotype to Phenotype to Teatment and Where Do We Stand? Int J Mol Sci. 2020;21(9):3297. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.